Production (Stage)
PharmaRoth Labs, Inc.
ROTH
$0.00
$0.000.00%
OTC PK
| 03/31/2011 | 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | -- | -- | -- | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | 17.14% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 189.02% | 17.14% | -- | -- | -- |
|
|
|||||
| Total Current Assets | 189.02% | 17.14% | -- | -- | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 189.02% | 17.14% | -- | -- | -- |
|
|
|||||
| Total Accounts Payable | 175.69% | 49.22% | 211.29% | -75.59% | 4.10% |
| Total Accrued Expenses | 43.10% | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -30.17% | 13.90% | -- | -- | 0.00% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -0.64% | 17.69% | 5,280.65% | -83.64% | 2.71% |
|
|
|||||
| Total Current Liabilities | -0.64% | 17.69% | 5,280.65% | -83.64% | 2.71% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -0.64% | 17.69% | 14.09% | 671.50% | 2.71% |
|
|
|||||
| Common Stock & APIC | 69.06% | 0.00% | 93.41% | 248.36% | 0.00% |
| Retained Earnings | -17.43% | -9.82% | -67.84% | -341.61% | -1.36% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 17.93% | -17.74% | -4.51% | -671.50% | -2.71% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 17.93% | -17.74% | -4.51% | -671.50% | -2.71% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 17.93% | -17.74% | -4.51% | -671.50% | -2.71% |
|
|
|||||